4D Molecular Therapeutics (FDMT) 2025 Conference June 04, 2025 03:45 PM ET Speaker0 All right. Welcome, everybody. Thank you. It's a pleasure to be here. I'm Dave Kern, co founder and CEO of four d Molecular Therapeutix, or four d MT. Welcome. Okay. We'll be giving some brief introductory remarks with a brief slide deck here today and then get into Q and A. 4,150 is our lead product for wet AMD and DME. Key updates here is the Forefront I Phase III trial is underway and enrolling briskly, which is very exci ...